Consilient have had a presence in Northern Ireland for 10 years now. We have seen business grow significantly on our “bedrock” generic business and also the more recent Branded products - Oral Contraceptives range now the largest in the UK and the growing Invita D3 “bone health” portfolio. Our Business development team continue to identify other “niche products” to complete our bespoke portfolio.


Consilient 1st to market generic strategy will continue into 2016 and beyond and we will be adding to our Women’s Health and Bone Health ranges in 2016. We shall also strive to bring further Niche products to market.


Can I take this opportunity to thank all our customers for their continued support, to congratulate all the finalists this year and especially our winner on a great achievement as Customer Service is a key element of any business and means so much within pharmacy.


Harpreet Sawhney


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64